Industry News
Biotechnology Industry News
GlaxoSmithKline takes aim at NASH, penning a $1B pact with RNAi biotech Arrowhead
GlaxoSmithKline takes aim at NASH, penning a $1B pact with RNAi biotech Arrowhead badams Mon, 11/22/2021 - 10:49
Neurocrine pens $2.6B biobucks pact with Sosei Heptares for next-gen neuro targets
Neurocrine pens $2.6B biobucks pact with Sosei Heptares for next-gen neuro targets badams Mon, 11/22/2021 - 08:57
Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal
Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal ntaylor Mon, 11/22/2021 - 08:33
Sanifit, having put Spain’s biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data
Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data ntaylor Mon, 11/22/2021 - 06:11
Twist nabs antibody discovery biotech Abveris for $190M a week after spinning out COVID unit
Twist nabs antibody discovery biotech Abveris for $190M a week after spinning out COVID unit badams Mon, 11/22/2021 - 05:59
Connect Biopharma touts positive results for Dupixent rival, but shares halved as investors await hard data
Connect Biopharma touts positive results for Dupixent rival, but shares halved as investors await hard data badams Mon, 11/22/2021 - 04:40
‘What it takes’: As Lilly’s Alzheimer’s drug approaches FDA, launch leader feels ‘amplified’ sense of excitement
'What it takes': As Lilly's Alzheimer's drug approaches FDA, launch leader feels 'amplified' sense of excitement aarmstrong Fri, 11/19/2021 - 12:44
‘What it takes’: Beyond the headlines, women are pushing groundbreaking new Alzheimer’s treatments forward
'What it takes': Beyond the headlines, women are pushing groundbreaking new Alzheimer's treatments forward aarmstrong Fri, 11/19/2021 - 11:53
New insights into how cancer cripples immune cells could fuel fresh I-O approaches
New insights into how cancer cripples immune cells could fuel fresh I-O approaches arlene.weintraub Fri, 11/19/2021 - 09:30
Enanta dumps oral hep B program after safety warnings in early test
Enanta dumps oral hep B program after safety warnings in early test badams Fri, 11/19/2021 - 08:13
Fresh from $2.5B pact, BridgeBio, Helsinn expand collaboration to cover preclinical cancer prospects
Fresh from $2.5B pact, BridgeBio, Helsinn expand collaboration to cover preclinical cancer prospects ntaylor Fri, 11/19/2021 - 07:28
Merck pauses ‘very important’ HIV program after seeing red flag in phase 2 trial of once-weekly combo
Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo ntaylor Fri, 11/19/2021 - 05:04
Personalized T cells could offer an immunotherapy option to children with brain tumors
Personalized T cells could offer an immunotherapy option to children with brain tumors arlene.weintraub Thu, 11/18/2021 - 13:54
Data manipulation expert Elisabeth Bik compares the tales of 2 accused biotechs: Cassava and Athira
Data manipulation expert Elisabeth Bik compares the tales of 2 accused biotechs: Cassava and Athira aarmstrong Thu, 11/18/2021 - 13:50
J&J previews $60B-a-year future with plans to go after viruses that have long evaded vaccine makers
J&J previews $60B-a-year future with plans to go after viruses that have long evaded vaccine makers aarmstrong Thu, 11/18/2021 - 12:26
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna ntaylor Thu, 11/18/2021 - 08:24
Gilead hits go on a host of Arcus cancer programs but forgoes rumored buyout in a $725M pact as TIGIT leads the way
Gilead hits go on a host of Arcus cancer programs but forgoes rumored buyout in a $725M pact as TIGIT leads the way badams Thu, 11/18/2021 - 07:50
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing antibodies
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing antibodies ntaylor Thu, 11/18/2021 - 06:31
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder klahucik Wed, 11/17/2021 - 15:53
Valo whacks SPAC merger, blaming ‘market conditions’ for end of $750M Khosla deal
Valo whacks SPAC merger, blaming 'market conditions' for end of $750M Khosla deal ntaylor Wed, 11/17/2021 - 08:53